Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-1.83%
↓ 105% below average
Average (2y)
-0.89%
Historical baseline
Range
High:-0.08%
Low:-1.83%
CAGR
+365.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -1.83% | -138.5% |
| 2023 | -0.77% | -809.4% |
| 2022 | -0.08% | - |